Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 21

Trial Status

Completed1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT05383482Phase 1/2Completed
Afuresertib +Sintilimab+Chemotherapy in Patients With Selected Solid Tumors That Resistance to Prior Anti-PD-1/PD-L1
Cervical CancerEndometrial CancerEsophageal Cancer+3 more
PrincipalinvestigatorStart date: 2022-07-01

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

You Lu, MD

West China Hospital

Related
18 trials

Shared therapeutic areas:

NSCLCCancer of the Uterine CervixSolid Tumor
Similarity Score15%

Lin Shen, MD

Peking University Cancer Hospital & Institute

Related
20 trials

Shared therapeutic areas:

Solid TumorCancer of EsophagusGastric and Gastroesophageal Junction Adenocarcinoma
Similarity Score15%

Zhenfeng Zhang, MD, PhD

Second Affiliated Hospital of Guangzhou Medical University

Related
21 trials

Shared therapeutic areas:

Cancer of the Uterine CervixCancer of EsophagusSolid Tumor
Similarity Score15%

Michael B Gill

Power Life Sciences Inc.

Related
105 trials

Shared therapeutic areas:

Cancer of the Uterine CervixEndometrial CarcinomaCancer of Esophagus
Similarity Score15%

Lung-Ji Chang, PhD

Shenzhen Geno-Immune Medical Institute

Related
18 trials

Shared therapeutic areas:

Cancer of the Uterine CervixNSCLC
Similarity Score10%

Lei Li, M.D.

Peking Union Medical College Hospital

Related
46 trials

Shared therapeutic areas:

Cancer of the Uterine CervixEndometrial Carcinoma
Similarity Score10%

Francesco Perrone, M.D., Ph.D.

National Cancer Institute, Naples

Related
13 trials

Shared therapeutic areas:

Cancer of the Uterine CervixEndometrial Carcinoma
Similarity Score10%

Xiaoli Lan, PhD

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Related
16 trials

Shared therapeutic areas:

Cancer of EsophagusNSCLC
Similarity Score10%

yuankai shi, MD

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Related
17 trials

Shared therapeutic areas:

Cancer of EsophagusSolid Tumor
Similarity Score10%

Rahul Aggarwal, MD

University of California, San Francisco

Related
22 trials

Shared therapeutic areas:

Solid TumorEndometrial Carcinoma
Similarity Score10%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT05383482Phase 1/2PrincipalInvestigator

Afuresertib +Sintilimab+Chemotherapy in Patients With Selected Solid Tumors That Resistance to Prior Anti-PD-1/PD-L1

Cervical CancerEndometrial CancerEsophageal Cancer+3 more
Completed

All 1 trials loaded